Casual onlookers may have a hard time digesting the broader implications of the virtual reality sector. Having personally stepped into the realm of digitalized ecosystems, I can tell you the practice takes some getting used to. At the same time, innovation is constantly moving forward, which makes the investment case for virtual reality stocks an intriguing one.
That’s really the main point about this market segment: no, it’s not going to appeal to absolutely everybody. Wearing a digital device on your head for extended periods isn’t exactly the most comfortable thing in the world. More critically, medical experts warn that VR headsets may cause temporary eye problems, such as strain or fatigue. Yet the narrative for virtual reality stocks continues to expand.
Whether you personally intend to use VR platforms or not, the question comes down to the numbers. And frankly, virtual reality stocks post very compelling ones. According to Grand View Research, the global VR market size reached a valuation of $15.81 billion last year. Further, it’s expected to increase at an 18% compound annual growth rate from 2021 to 2028. By the end of the aforementioned period, the market could command revenues of $69.6 billion.
Top 5 Medical Stocks To Watch For 2023: Abbott Laboratories(ABT)
Abbott Laboratories is an Illinois corporation, incorporated in 1900. Abbott’s* principal business is the discovery, development, manufacture, and sale of a broad and diversified line of health care products.
FINANCIAL INFORMATION RELATING TO INDUSTRY SEGMENTS, GEOGRAPHIC AREAS, AND CLASSES OF SIMILAR PRODUCTS
Incorporated herein by reference is Note 15 entitled “Segment and Geographic Area Information” of the Notes to Consolidated Financial Statements included under Item 8, “Financial Statements and Supplementary Data.”
NARRATIVE DESCRIPTION OF BUSINESS
Abbott has four reportable segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular Products.
Prior to January 1, 2013, Abbott had five reportable segments, which included Proprietary Pharmaceutical Products. Advisors’ Opinion:
- [By ]
The company also has a Sentiment Grade of B, which means it has shown consistent growth and price performance. For instance, the stock has a beta of 0.63, which indicates it is not very volatile. See the complete POWR Ratings analysis for Abbott Laboratories (ABT) here.
- [By Will Ashworth]
I commented that in the nearly nine years since the company was spun-off by Abbott Laboratories (NYSE:ABT), it’s grown revenues 149% to $45.8 billion in 2020.
- [By ]
IHI's top positions among its 60-something holdings at present include insertable heart monitor maker Abbott Laboratories (ABT), specialty diagnostics firm Thermo Fisher Scientific (TMO) and cellular analysis specialist Danaher (DHR). The healthcare fund is admittedly pretty focused on this trio, with 36% of all assets in the three positions, but they are entrenched and stable ways to play the sector without worrying about drug patent expirations.
Top 5 Medical Stocks To Watch For 2023: AVG Technologies N.V.(AVG)
AVG Technologies N.V., incorporated on March 3, 2011, provides software and online services. The Company operates through two segments: Consumer and small and medium sized business (SMB). The Consumer segment reflects all direct (subscription) and indirect (platform) revenues targeted at the Consumer segment and including the Location Labs business, and Privax entity. The SMB segment reflects all direct (subscription) revenue targeted at the SMB segment and includes the revenue from the Norman Safeground AS. Its product portfolio includes AVG Anti-Virus FREE, AVG Anti-Virus, AVG Internet Security, AVG Protection FREE suite, AVG Protection PRO suite, AVG Performance suite, AVG Ultimate suite, Anti-Virus Security-FREE, AVG Zen, Mobile Anti-Virus Security-PRO, AVG Cleaner–Mobile Booster & Battery Saver, Gallery, Gallery Doctor, AVG Anti-Virus for Mac, TuneUp Utilities and AVG PC Tuneup, AVG Cleaner for Mac, AVG Driver Updater, AVG Web TuneUp, Alarm Clock Xtreme FREE + Timer, AVG Cleaner-Xperia and HideMyPhone, among others. Its location labs mobile solutions include AT&T FamilyMap, AT&T Smart Limits, Sprint Family Locator, Sprint Mobile Controls, Sprint Drive First, T-Mobile FamilyWhere, Verizon FamilyBase, Safely Go and Aqui Estoy.
The Company’s SMB security platform, AVG CloudCare, enables information technology (IT) management by allowing cloud services and devices to be remotely managed from any Web browser or Android and iPhone operating system (iOS) mobile device applications. IT providers can manage multiple customers from a single cloud dashboard, activate services with a single click, generate a variety of reports, view real-time alerts to problems, and drag and drop documents to create centralized policies. Its AVG CloudCare Products include AVG Remote IT, AVG Anti-Virus, AVG Content Filtering, AVG Cloud Backup and AVG Email Security. Its Norman solutions include Norman Antivirus, Norman Security Suite, Norman Security Suite PRO, Norman Endpoint Protection, Norman Email Protection, Norman Security Portal, Norman SecureMail and Norman SecureSurf. Its product portfolio targets the consumer and SMB markets across multiple devices and operating systems and includes Internet security, personal computer (PC) performance optimization, online backup, identity protection, family safety, mobile control and location services, dynamic secure search, remote control, network auditing, monitoring and alerting software. Its product portfolio also includes virtual private network services.
The Company’s solutions, encompassing software and online services, include security, PC optimization, online privacy, cloud-based desktop management, mobile security, management and location services, content filtering, remote monitoring and other products on various desktop and mobile operating systems. Its software products are available in various languages; used in multiple countries across the world, and sold under software license agreements. They are generally sold and downloaded over the Internet or sold as packaged products through multi-tiered distribution channels. The Company offers AVG Zen, a connected solution across both mobile and PC platforms in order to support expansion into mobile. Through its AVG Business Solutions, the Company offers both security and cloud-based remote monitoring and IT management, and the Company offers both license subscription-based and software-as-a-service (SaaS)-based (monthly) billing. The Company also distributes through resellers and distributors, which the Company refers to as its reseller network.
The Company competes with Avast!, Avira, Symantec, Carbonite, Dropbox, Intel Corporation, Trend Micro, Eset, Kaspersky Labs, Panda Software, Sophos, Bit Defender, Rising, Kingsoft, Check Point, Qihoo, F-Secure, Private Internet Access, Anchor Free, Tunnelbear, UniBlue, Piriform, Kaseya, Solarwinds, Cheetah Mobile, NQ Mobile, Lookout, CM security, Microsoft, Google, Apple, Tencent, Facebook, Lifelock and Life 360.
Advisors’ Opinion:
- [By Shane Hupp]
FinnCap cut shares of Avingtrans (LON:AVG) to a corporate rating in a research report report published on Monday.
Shares of LON:AVG opened at GBX 223 ($2.97) on Monday. Avingtrans has a one year low of GBX 174.11 ($2.32) and a one year high of GBX 260 ($3.46).
Top 5 Medical Stocks To Watch For 2023: Lam Research Corporation(LRCX)
Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing systems used in the fabrication of integrated circuits. It provides thin film deposition products, including SABRE electrochemical deposition products for copper damascene manufacturing; ALTUS systems to deposit conformal atomic layer films for tungsten metallization applications; VECTOR plasma-enhanced chemical vapor deposition and atomic layer deposition systems to deposit oxides, nitrides, carbides, multiple patterning films, anti-reflective layers, multi-layer stack films, and diffusion barriers; SPEED high-density plasma-chemical vapor deposition products for applications in shallow trench isolation, pre-metal dielectrics, inter-layer dielectrics, inter-metal dielectrics, and passivation layers; and SOLA ultraviolet thermal processing products for the treatment of back-end-of-line low-k dielectric films and front-end-of-line silicon nitride strained films. The company also offers plasma etch products, such as Kiyo products that provide solutions for conductor etch applications; Flex products, which offer technologies and application-focused capabilities for dielectric etch applications; and Syndion products that provide solutions to address various through-silicon via etch applications. In addition, it provides single-wafer clean products, including EOS, Da Vinci, DV-Prime, and SP series products for wet etch and clean applications in wafer-level packaging , including silicon substrate thinning, wafer stress relief, underbump metallization etch, and photoresist removal; and Coronus plasma-based bevel clean products to enhance die yield by removing particles, residues, and unwanted films from the wafers edge, as well as legacy products. The company offers its products in the United States, Europe, Taiwan, Korea, Japan, China, and Southeast Asia. Lam Research Corporation was founded in 1980 and is headquartered in Fremont, California.
Advisors’ Opinion:
- [By Joseph Griffin]
Get a free copy of the Zacks research report on FreightCar America (RAIL)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Ethan Ryder]
Wells Fargo & Company MN increased its stake in FreightCar America, Inc. (NASDAQ:RAIL) by 95.9% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 730,734 shares of the transportation company’s stock after acquiring an additional 357,670 shares during the period. Wells Fargo & Company MN owned about 5.87% of FreightCar America worth $9,790,000 as of its most recent SEC filing.
